Back to search
FDAFDA · Food and drugs·Recall number D-0635-2020

Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.

Published January 8, 2020 · Recall initiated: December 13, 2019

Summary

FDA records drug Class III recall D-0635-2020, published January 8, 2020 and initiated December 13, 2019. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 2,130 bottles; Lot: Lot# H801686, Exp. 12/31/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide in the U.S.
Lot
Lot# H801686, Exp. 12/31/2019.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03. recalled?

Yes. FDA published recall D-0635-2020 on January 8, 2020. Reported hazard: Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter